Carole Nuechterlein - Director at Aligos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ALGS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Carole Nuechterlein since 12/23/2023

Holdings reported by Carole Nuechterlein for Aligos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 11M $8.34M $0.76 Oct 25, 2023 Indirect
Warrant (Right to Buy) 3.97M Oct 25, 2023 Indirect Common Stock
Stock Option (Right to Buy) 60K Jun 27, 2024 Direct Common Stock

Transactions reported by Carole Nuechterlein for Aligos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.